T. Otto

546 total citations
20 papers, 375 citations indexed

About

T. Otto is a scholar working on Oncology, Sensory Systems and Cellular and Molecular Neuroscience. According to data from OpenAlex, T. Otto has authored 20 papers receiving a total of 375 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 5 papers in Sensory Systems and 4 papers in Cellular and Molecular Neuroscience. Recurrent topics in T. Otto's work include Cancer Immunotherapy and Biomarkers (9 papers), Colorectal Cancer Treatments and Studies (6 papers) and Olfactory and Sensory Function Studies (5 papers). T. Otto is often cited by papers focused on Cancer Immunotherapy and Biomarkers (9 papers), Colorectal Cancer Treatments and Studies (6 papers) and Olfactory and Sensory Function Studies (5 papers). T. Otto collaborates with scholars based in United States, France and Italy. T. Otto's co-authors include Graham Cousens, Michela Gallagher, Howard Eichenbaum, Christopher D. Herzog, Steven T. Chen, Frank Schottler, Kerry L. Reynolds, John Larson, Alexa B. Kimball and Leah L. Thompson and has published in prestigious journals such as Journal of Neuroscience, Neuroscience and Journal of the American Academy of Dermatology.

In The Last Decade

T. Otto

18 papers receiving 366 citations

Peers

T. Otto

CMN

Chun-Li Li China

Meizhu Huang China

Samuli Kemppainen Finland

Isabella Garcia United States

Xenos Mason United States

Pedro Garrido Spain

Laura E. Mickelsen United States

M. Raso Italy

Andrew M. Rosen United States

Kathleen R. Bailey United States

Chun-Li Li China

T. Otto

76 ×0.3

81 ×0.5

CMN

59 ×0.6

36 ×0.3

85 ×1.3

Citations per year, relative to T. Otto T. Otto (= 1×) peers Chun-Li Li

Countries citing papers authored by T. Otto

Since Specialization

Citations

This map shows the geographic impact of T. Otto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by T. Otto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites T. Otto more than expected).

Fields of papers citing papers by T. Otto

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by T. Otto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by T. Otto. The network helps show where T. Otto may publish in the future.

Co-authorship network of co-authors of T. Otto

This figure shows the co-authorship network connecting the top 25 collaborators of T. Otto. A scholar is included among the top collaborators of T. Otto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with T. Otto. T. Otto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Otto, T., et al.. (2024). Oral Psoriasis Therapies. Dermatologic Clinics. 42(3). 357–363. 1 indexed citations

Gao, Julia, T. Otto, Martina L. Porter, & Alexa B. Kimball. (2024). Hidradenitis Suppurativa: New Targets and Emerging Treatments. American Journal of Clinical Dermatology. 25(5). 765–778. 6 indexed citations

Stephens, Michael, Maria S. Asdourian, Nishi Shah, et al.. (2023). Tumor-infiltrating lymphocytes as a predictive biomarker of cutaneous immune-related adverse events after immune checkpoint blockade in patients with advanced melanoma. Journal of the American Academy of Dermatology. 89(1). 140–142. 5 indexed citations

Asdourian, Maria S., Nishi Shah, T. Otto, et al.. (2023). Noncutaneous immune-related adverse events predict overall and progression-free survival in patients with cutaneous toxicities after immune checkpoint inhibitor therapy. Journal of the American Academy of Dermatology. 88(6). 1368–1370. 2 indexed citations

Otto, T., Emily Baumrin, Adela R. Cardones, et al.. (2023). Detection of novel therapies using a multi‐national, multi‐institutional registry of cutaneous immune‐related adverse events and management. International Journal of Dermatology. 62(8). 1020–1025. 3 indexed citations

Asdourian, Maria S., T. Otto, Leah L. Thompson, et al.. (2022). Association between serum lactate dehydrogenase and cutaneous immune-related adverse events among patients on immune checkpoint inhibitors for advanced melanoma. Journal of the American Academy of Dermatology. 87(5). 1147–1149. 5 indexed citations

Asdourian, Maria S., Yevgeniy R. Semenov, T. Otto, et al.. (2022). Development of multiple cutaneous immune-related adverse events among cancer patients after immune checkpoint blockade. Journal of the American Academy of Dermatology. 88(2). 485–487. 4 indexed citations

Asdourian, Maria S., Leah L. Thompson, T. Otto, et al.. (2022). Dermatology evaluation for cutaneous immune-related adverse events is associated with improved survival in cancer patients treated with checkpoint inhibition. Journal of the American Academy of Dermatology. 88(3). 711–714. 7 indexed citations

Asdourian, Maria S., Leah L. Thompson, T. Otto, et al.. (2022). Morphologic characteristics of cutaneous immune-related adverse events in patients receiving immune checkpoint inhibitors combined with other anticancer therapies: A multicenter retrospective study. Journal of the American Academy of Dermatology. 88(2). 474–476.

10.

Sayegh, Eli T., et al.. (2022). Defining the Opioid Requirement in Anterior Cruciate Ligament Reconstruction. JAAOS Global Research and Reviews. 6(1). 8 indexed citations

11.

Asdourian, Maria S., Leah L. Thompson, T. Otto, et al.. (2022). Evaluating patterns of co-occurrence between cutaneous and noncutaneous immune-related adverse events after immune checkpoint inhibitor therapy. Journal of the American Academy of Dermatology. 88(1). 246–249. 2 indexed citations

12.

Otto, T., Sacharitha Bowers, & Steven T. Chen. (2021). Dermatology's dearth of diversity: Considerations in providing support to students underrepresented in medicine at home and away. International Journal of Women’s Dermatology. 7(4). 514–515. 2 indexed citations

13.

Otto, T., et al.. (2021). Cognitive decline associated with normal aging in rats: a neuropsychological approach.. UNC Libraries.

14.

Otto, T., et al.. (2006). Dorsal Hippocampal Contributions to Unimodal Contextual Conditioning. Journal of Neuroscience. 26(24). 6603–6609. 36 indexed citations

15.

Herzog, Christopher D. & T. Otto. (2002). Administration of transforming growth factor-α enhances anatomical and behavioral recovery following olfactory nerve transection. Neuroscience. 113(3). 569–580. 16 indexed citations

16.

Cousens, Graham & T. Otto. (1998). Both pre- and posttraining excitotoxic lesions of the basolateral amygdala abolish the expression of olfactory and contextual fear conditioning.. Behavioral Neuroscience. 112(5). 1092–1103. 115 indexed citations

17.

Otto, T., et al.. (1997). Odor-guided fear conditioning in rats: 1. Acquisition, retention, and latent inhibition.. PubMed. 111(6). 1257–64. 52 indexed citations

18.

Jankevičius, Feliksas, et al.. (1995). [Prognostic factors for predicting the success of immunotherapy in metastatic renal cell carcinoma].. PubMed. 34(3). 195–9. 2 indexed citations

19.

Otto, T., et al.. (1995). Cognitive decline associated with normal aging in rats: a neuropsychological approach.. Learning & Memory. 2(1). 1–16. 100 indexed citations

20.

Larson, John, et al.. (1991). Short-latency single unit processing in olfactory cortex. - eScholarship. 3(3). 293–299. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact